(VIANEWS) – Shares of ImmunoGen (NASDAQ: IMGN) dropped by a staggering 23.47% in 14 days from $5.08 to $3.89 at 14:34 EST on Monday, following the last session’s downward trend. NASDAQ is falling 0.37% to $11,761.46, after two sequential sessions in a row of gains.

ImmunoGen’s last close was $3.83, 53.41% under its 52-week high of $8.22.


Today’s last reported volume for ImmunoGen is 3265864 which is 16.75% below its average volume of 3923406.

ImmunoGen’s Sales

ImmunoGen’s sales growth is a negative 70.1% for the current quarter and a decline by 39.2% for the next. The company’s growth estimates for the present quarter and the next is a negative 1262.5% and a negative 35.3%, respectively.

ImmunoGen’s Revenue

Year-on-year quarterly revenue growth declined by 49.4%, now sitting on 127.66M for the twelve trailing months.


ImmunoGen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.32%, a negative 2.32%, and a positive 4.25%, respectively.

ImmunoGen’s highest amplitude of average volatility was 6.71% (last week), 4.38% (last month), and 4.25% (last quarter), respectively.

ImmunoGen’s Stock Yearly Top and Bottom Value

ImmunoGen’s stock is valued at $3.89 at 14:34 EST, way under its 52-week high of $8.22 and above its 52-week low of $3.83.

ImmunoGen’s Moving Average

ImmunoGen’s value is way below its 50-day moving average of $5.11 and way below its 200-day moving average of $5.76.

More news about ImmunoGen (IMGN).


Please enter your comment!
Please enter your name here